AstraZeneca PLC

LSE-AZN

Operating Activities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Net Income	6,529	3,494	5,197	2,549	4,350	1,701
Profit Before Tax
Depreciation & Amortization	2,673	4,154	2,534	2,609	2,778	2,814
Depreciation, Amortisation and Impairment
Other Adjustments	840	1,094	344	1,192	14	527
Finance Income and Expense
Share of After Tax Income of Associates and Joint Ventures
Gains on Disposal of Intangible Assets
Gains on Disposal of Investments in Associates and Joint Ventures
Fair Value Movements on Contingent Consideration Arising from Business Combinations
Non-Cash and Other Movements
Changes in Trade Receivables	—	-1,624	—	-1,425	—	-1,349
Change in Trade and Other Receivables
Changes in Inventories	—	-131	—	-669	—	3,941
Change in Inventories
Changes in Accounts Payable	—	862	—	2,394	—	1,165
Change in Trade and Other Payables and Provisions
Changes in Income Taxes Payable	-1,549	-1,413	-1,337	-1,305	-1,061	-617
Tax Paid
Changes in Other Operating Activities	-1,394	-146	-1,167	149	-1,230	-2,854
Change in Working Capital and Short-Term Provisions
Interest Paid
Cash from Operating Activities	7,099	6,290	5,571	5,494	4,851	5,328
Net Cash Inflow from Operating Activities

Investing Activities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Capital Expenditure	-1,088	-1,125	-799	-844	-517	-619
Purchase of Property, Plant and Equipment
Proceeds from Sale of Property, Plant & Equipment	10	2	53	6	126	282
Disposal of Property, Plant and Equipment
Purchases of Intangible Assets	-1,804	-1,188	-1,474	-981	-1,436	-1,046
Purchase of Intangible Assets
Proceeds from Sale of Intangible Assets	95	48	75	3	288	5
Disposal of Intangible Assets
Purchases of Investments	-188	-29	-67	-110	-26	-17
Purchase of Non-Current Asset Investments
Proceeds from Sale of Investments	115	15	93	29	100	-116
Disposal of Non-Current Asset Investments
Change in Short-Term Investments, Fixed Deposits and Other Investing Instruments
Payments for Business Acquisitions	-629	-537	-3,245	-489	-610	-510
Non-Contingent Payments on Business Combinations
Acquisition of Subsidiaries, Net of Cash Acquired
Payments Upon Vesting of Employee Share Awards Attributable to Business Combinations
Payment of Contingent Consideration from Business Combinations
Other Investing Activities	128	119	79	88	309	29
Change in Profit-Participation Liability
Payments to Associates and Joint Ventures
Disposal of Investments in Associates and Joint Ventures
Interest Received
Payments Made by Subsidiaries to Non-Controlling Interests
Cash from Investing Activities	-3,361	-2,695	-5,285	-2,298	-1,766	-1,992
Net Cash Inflow from Investing Activities

Financing Activities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Issuance of Long-Term Debt	9	1,516	4,976	—	3,816	—
Issue of Loans and Borrowings
Repayments of Long-Term Debt	-16	-2,009	-2,643	-1,534	-3,408	-14
Repayment of Loans and Borrowings
Net Issuance / (Repayments) of Long-Term Debt	-7	-493	2,333	-1,534	408	-14
Issuance of Common Shares	12	27	11	25	8	21
Proceeds from Issue of Share Capital
Repurchases of Common Shares	-489	-81	—	—	—	—
Own Shares Purchased by Employee Benefit Trusts
Net Issuance / (Repurchases) of Common Shares	-477	-54	11	25	8	21
Common Share Dividends Paid	-3,253	-1,555	-3,058	-1,458	-3,042	-1,443
Dividends Paid
Hedge Contracts Relating to Dividend Payments
Other Financing Activities	1,548	-2,700	1,520	-50	-924	-352
Payments to Acquire Non-Controlling Interests
Repayment of Obligations Under Leases
Change in Short-Term Borrowings
Payment of Acerta Pharma Share Purchase Liability
Cash from Financing Activities	-2,189	-4,802	806	-3,017	-3,550	-1,788
Net Cash Inflow from Financing Activities